Clinical features of renal cell carcinoma (RCC) found in 110 nephrectomized Japanese, of which 24 (22%) RCC cases showed 31 double or triple cancers

Abstract

The causes of renal cell carcinoma (RCC) were investigated in 115 nephrectomized Japanese. Among them, 110 nephrectomized Japanese had RCC as follows: 86 clear cell RCC, 8 papillary RCC, 8 chromophobe RCC, 7 dialytic–multicystic RCC, and 1 liposarcoma, while 5 nephrectomized Japanese had benign renal tumors of oncocytoma (1), angiomyolipoma (2), and hemangioma (2). In the eight chromophobe RCC, three cases that resulted in death involved medullary RCC showing extensive oncogenic features. Double or triple cancers were found in 17 clear cell RCC, 5 papillary RCC, 1 chromophobe RCC, and 1 dialytic–multicystic RCC. Among 31 non-RCC found in 24 RCC cases, 23(74%) non-RCC were removed prenephrectomy. Prenephrectomy adenocarcinoma and postnephrectomy squamous cell carcinoma were their characteristic findings. Compared with those of clear cell RCC, double (triple) cancers of papillary RCC showed more aggressive malignancy. One clear cell RCC had triple cancer of thymoma and rectum cancer. One chromophobe RCC developed thymoma, while one oncocytoma had insulinoma >10 years before. A patient in his sixties with clear cell RCC, who had a past history of pneumothorax, had developed adenocarcinoma of colon polyps and liver adenocarcinoma almost at the same time as triple cancer. His lactate dehydrogenase (LDH) levels were under 300 IU/l. He was suspected of having Birt–Hogg–Dube syndrome. One patient with papillary RCC of Paget’s disease of the bone developed colon polyp adenocarcinoma, osteosarcoma, and additionally exhibited p97/valosin-containing protein downregulation in his sixties. His LHD was increased to 4,289 IU/l with cell lysis reactions. His radical nephrectomy accompanied by adrenalectomy reinforced clinical manifestations of p97 downregulation. For p97 functions, the kidney and adrenal gland had important roles. It was concluded that oxygen stress was stronger in RCC, especially in papillary RCC. Nonsense mutations of protein tyrosine phosphatase receptor delta might be one cause of double (triple) cancers in RCC.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Arai E, Kanai Y (2011) Genetic and epigenetic alterations during renal carcinogenesis. Int J Clin Exp Pathol 4:58–73

    Google Scholar 

  2. Arai E, Wakai-Ushijima S, Fujimoto H et al (2011) Genome-wide DNA methylation profiles in renal tumors of various histological subtypes and non-tumorous renal tissues. Pathobiology 78:1–9

    CAS  Google Scholar 

  3. Chapman-Fredricks JR, Herrera L, Bracho J et al (2011) Adult renal cell carcinoma with rhabdoid morphology represents a neoplastic dedifferentiation analogous to sarcomatoid carcinoma. Ann Diagn Pathol 15:333–337

    PubMed  Article  Google Scholar 

  4. Cheng JX, Tretiakova M, Gong C et al (2008) Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol 21:647–652

    PubMed  Article  CAS  Google Scholar 

  5. Farpour F, Tehranzadeh J, Donkervoort S et al (2011) Radiological features of Paget disease of bone associated with VCP myopathy. Skeletal Radiol. doi:10.1007/s00256-011-1193-4

  6. Frew IJ, Krek W (2007) Multitasking by pVHL in tumor suppression. Curr Opin Cell Biol 19:685–690

    PubMed  Article  CAS  Google Scholar 

  7. Goode A, Layfield R (2010) Recent advances in understanding the molecular basis of Paget disease of bone. J Clin Pathol 63:199–203

    PubMed  Article  CAS  Google Scholar 

  8. Iijima M, Fukino K, Adachi M et al (2011) Sorafenib-associated hand–foot syndrome in Japanese patients. J Dermatol 38:261–266

    PubMed  Article  CAS  Google Scholar 

  9. Jung C-R, Hwang K-S, Yoo J et al (2006) E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis. Nat Med 12:809–816

    PubMed  Article  CAS  Google Scholar 

  10. Kennoki T, Kondo T, Kimata N et al (2011) Clinical results and pharmacokinetics of sorafenib in chronic hemodialysis patients with metastatic renal cell carcinoma in s single center. Jpn J Clin Oncol 41:647–655

    PubMed  Article  Google Scholar 

  11. Khoo SK, Giraud S, Kahnoski K et al (2002) Clinical and genetic studies of Birt–Hogg–Dube syndrome. J Med Genet 39:906–912

    PubMed  Article  CAS  Google Scholar 

  12. Klomp JA, Petillo D, Niemi NM et al (2010) Birt–Hogg–Dube renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression. BMC Med Genomics 3:59

    PubMed  Article  CAS  Google Scholar 

  13. Kohno T, Otsuka A, Girard L et al (2010) A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene. Genes Chromosomes Cancer 49:342–352

    CAS  Google Scholar 

  14. Komai Y, Fujii Y, Iimura Y et al (2011) Young age as favorable prognostic factor for cancer-specific survival in localized renal cell carcinoma. Urology 77:842–848

    PubMed  Article  Google Scholar 

  15. Kuroda N, Tamura M, Hamaguchi N et al (2010) Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features. Ann Diagn Pathol 15:462–466

    PubMed  Article  Google Scholar 

  16. Li X, Tan X, Yu Y et al (2011) D9S168 microsatellite alteration predicts a poor prognosis in patients with clear cell renal cell carcinoma and correlates with the down-regulation of protein tyrosine phosphatase receptor delta. Cancer 117:4201–4211

    Google Scholar 

  17. Martin KR, Xu Y, Looyenga BD et al (2011) Identification of PTP σ as an autophagic phosphatase. J Cell Sci 124:812–819

    PubMed  Article  CAS  Google Scholar 

  18. Moghadamfalahi M, Alatassi H (2011) Renal cell carcinoma with extensive oncocytic features. Int J Surg Pathol. doi:10.1177/1066896911420142

  19. Muramaki M, Miyake H, Sakai I et al (2011) Age at diagnosis as a powerful predictor for disease recurrence after radical nephrectomy in Japanese patients with pT1 renal cell carcinoma. Int J Urol 18:121–125

    PubMed  Article  Google Scholar 

  20. Noon AP, Polanski R, El-Fert AY et al (2011) Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy. BJU Int. doi:10.1111/j.1464-410X.2011.10433.x

  21. Nyhan MJ, El Mashad SM, O’Donovan TR et al (2011) VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin. Cell Oncol (Dordr) 34:225–234

    Article  CAS  Google Scholar 

  22. Preston RS, Philp A, Claessens T et al (2011) Absence of the Birt–Hogg–Dube gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility. Oncogene 30:1159–1173

    PubMed  Article  CAS  Google Scholar 

  23. Roos FC, Evans AJ, Brenner W et al (2011) Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinoma. Am J Pathol 178:853–860

    PubMed  Article  CAS  Google Scholar 

  24. Savage SA, Mirabello L (2011) Using epidemiology and genomics to understand osteosarcoma etiology. Sarcoma 2011:548151

    PubMed  Article  Google Scholar 

  25. Shannon BA, Cohen RJ (2003) Rhabdoid differentiation of chromophobe renal cell carcinoma. Pathology 35:228–230

    PubMed  Article  Google Scholar 

  26. Sudarshan S, Sourbier C, Kong H-S et al (2009) Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1α stabilization by glucose-dependent generation of reactive oxygen species. Mol Cell Biol 29:4080–4090

    PubMed  Article  CAS  Google Scholar 

  27. Tan M-H, Wong CF, Tan HL et al (2010) Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma. BMC Cancer 10:196

    PubMed  Article  Google Scholar 

  28. Tomita Y (2010) Editorial comment to treatment outcomes of sorafenib for first line or cytokine-refractory advanced renal cell carcinoma in Japanese patients. Int J Urol 17:815–816

    PubMed  Article  Google Scholar 

  29. Veeriah S, Brennan C, Meng S et al (2009) The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. PNAS 106:9435–9440

    PubMed  CAS  Google Scholar 

  30. Yamanaka K, Sasagawa Y, Ogura T (2011) Recent advances in p97/VCP/Cdc48 cellular functions. Biochim Biophys Acta 1823:130–137

    PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Tadako Nakatsuji.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Nakatsuji, T. Clinical features of renal cell carcinoma (RCC) found in 110 nephrectomized Japanese, of which 24 (22%) RCC cases showed 31 double or triple cancers. Comp Clin Pathol 22, 367–378 (2013). https://doi.org/10.1007/s00580-012-1418-5

Download citation

Keywords

  • Japanese
  • Nephrectomy
  • Renal cell carcinoma
  • Double (triple) cancer
  • Carcinogenesis
  • Immunochemical antibody stain